kabutan

Alfresa Holdings Corporation(2784) Summary

2784
TSE Prime
Alfresa Holdings Corporation
2,386.5
JPY
-6.5
(-0.27%)
Mar 13, 3:30 pm JST
14.97
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
12.0
PBR
0.87
Yield
2.85%
Margin Trading Ratio
0.65
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
2,371.0 JPY 14.89 USD
Previous Close Mar 12
2,393.0 JPY 15.05 USD
High Mar 13, 9:52 am
2,417.5 JPY 15.19 USD
Low Mar 13, 9:00 am
2,371.0 JPY 14.89 USD
Volume
371,500
Trading Value
0.89B JPY 5.55M USD
VWAP
2383.45 JPY 14.95 USD
Minimum Trading Value
238,650 JPY 1,497 USD
Market Cap
0.46T JPY 2.87B USD
Number of Trades
949
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
1,183
1-Year High May 15, 2025
4,934
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 37,000 10,500 0.28
Feb 27, 2026 28,600 16,400 0.57
Feb 20, 2026 23,800 13,000 0.55
Feb 13, 2026 21,600 19,800 0.92
Feb 6, 2026 24,600 20,100 0.82
Company Profile
Alfresa Holdings Corporation is Japan's largest pharmaceutical wholesaler. The company was formed through the merger of Fukujin and Azwell. It also engages in pharmaceutical contract manufacturing and medical equipment sales.
Sector
Wholesale Trade
Alfresa Holdings Corporation operates in pharmaceutical wholesale, self-medication wholesale, pharmaceutical manufacturing, and healthcare-related businesses. In its core medical pharmaceutical wholesale business, the company operates nationwide, centered around Alfresa. The self-medication wholesale business handles over-the-counter drugs and health foods. In the pharmaceutical manufacturing business, Alfresa Pharma Corporation manufactures and sells pharmaceuticals and medical diagnostic reagents. The healthcare-related business operates a chain of dispensing pharmacies. As a holding company, Alfresa Holdings Corporation formulates group-wide management policies and business plans, aiming to effectively utilize management resources and continuously enhance corporate value.